BioClinica (BIOC) +19.2% premarket after agreeing to be acquired by a holding company controlled...

|By:, SA News Editor

BioClinica (BIOC) +19.2% premarket after agreeing to be acquired by a holding company controlled by JLL Partners for $7.25/share, a 23.2% premium over its average closing price for the 90 days ended Jan. 29. Following the merger, BIOC will be merged with another JLL acquisition, medical imaging company CoreLab Partners.